Expression of VEGF, BMP-2, and the OPG/RANK axis as indicators of osseointegration: a comparative clinical and experimental study of titanium implants with functional protective coatings
DOI:
https://doi.org/10.26641/2307-0404.2025.4.348747Keywords:
osteoinduction, osteoconduction, osseointegration, titanium implant, alumina, translational study, vascular-endothelial growth factor (VEGF), receptor of vascular-endothelial growth factor (VEGFR), bone morphogenetic protein 2 (BMP-2), osteoprotegerin/receptor activator of nuclear factor κB (OPG/RANK) axis, bone remodeling, immunohistochemistry, enzyme-linked immunosorbent assay (ELISA)Abstract
The objective of the present study was to validate key molecular markers of bone tissue repair as indicators of osseointegration on systemic and local levels, and evaluate their translational parallelism. This was achieved by comparing the configurational consistency of expression profiles between an experimental rat model and a pilot clinical investigation in human patients to synchronize systemic and local molecular responses. The hypothesis was that alumina-coated titanium implants would exhibit faster dynamics of angiogenic and osteogenic biomarkers, indicating accelerated osteoinduction, osteoconduction, and osseointegration compared with uncoated titanium. The pilot clinical study comprised the patients after total hip arthroplasty (n=6): three with uncoated titanium implants and three with alumina ceramics. Serum samples were collected from these patients in one and six months post-surgery. The experimental rat model comprised 160 Wistar females implanted with modified intrafemoral implants (seven surface types, including uncoated and alumina-coated titanium), with serum and peri-implant tissue samples collected in one, two, four, and eight weeks. Serum levels of vascular endothelial growth factor, bone morphogenetic protein 2, and osteoprotegerin were determined by enzyme-linked immunosorbent assay, while the corresponding local expression of vascular endothelial growth factor receptor, bone morphogenetic protein 2, and receptor activator of nuclear factor kappa-B was assessed by immunohistochemistry. The results demonstrated that alumina-coated implants induced an accelerated and synchronized molecular cascade in the rat model, which was qualitatively replicated in the clinical cohort. The systemic vascular endothelial growth factor peak manifested early, at one week in rats and one month in humans, and exhibited a strong parallelism with local microvessel density in the animal model, confirming rapid angiogenic activation. In both species, the expression of bone morphogenetic protein 2 increased earlier and to a greater extent in the alumina-coated groups, indicating more rapid osteoinduction. Local receptor activator of nuclear factor kappa-B activity demonstrated an early rise and a four-week peak in the groups with coated implants, consistent with controlled and timely bone remodelling. The study indicates that alumina coatings promote accelerated osseointegration by advancing the time course of healing, a conclusion supported by the observed translational parallelism of the investigated markers.
References
Helaehil JV, Huang B, Bartolo P, Santamaria-Jr M, Caetano GF. Bone regeneration: The influence of composite HA/TCP scaffolds and electrical stimulation on TGF/BMP and RANK/RANKL/OPG pathways. Injury. 2025;56(2):112158. doi: https://doi.org/10.1016/j.injury.2025.112158
Tan B, Liu X, Chen S, et al. An injectable nano-hydroxyapatite-incorporated hydrogel with sustained release of Notoginsenoside R1 enhances bone regeneration by promoting angiogenesis through Notch1/Akt signaling. J Adv Res. 2025 May 13:S2090-1232(25)00343-1. doi: https://doi.org/10.1016/j.jare.2025.05.025
Cao L, Wang J, Hou J, Xing W, Liu C. Vascularization and bone regeneration in a critical sized defect using 2-N,6-O-sulfated chitosan nanoparticles incorpo-rating BMP-2. Biomaterials. 2014;35(2):684-98. doi: https://doi.org/10.1016/j.biomaterials.2013.10.005
Ramazanoglu M, Lutz R, Rusche P, et al. Bone response to biomimetic implants delivering BMP-2 and VEGF: an immunohistochemical study. J Craniomaxil-lofac Surg. 2013;41(8):826-35. doi: https://doi.org/10.1016/j.jcms.2013.01.037
Verisqa F, Park JH, Mandakhbayar N, et al. In Vivo Osteogenic and Angiogenic Properties of a 3D-Printed Isosorbide-Based Gyroid Scaffold Manufactured via Digital Light Processing. Biomedicines. 2024;12(3):609. doi: https://doi.org/10.3390/biomedicines12030609
Steiner D, Reinhardt L, Fischer L, et al. Impact of Endothelial Progenitor Cells in the Vascularization of Osteogenic Scaffolds. Cells. 2022;11(6):926. doi: https://doi.org/10.3390/cells11060926
Astudillo Potes MD, Mitra I, Hanson K, et al. Biodegradable poly(caprolactone fumarate) 3D printed scaf-folds for segmental bone defects within the Masquelet technique. J Orthop Res. 2024;42(9):1974-83. doi: https://doi.org/10.1002/jor.25839
Al Qabbani A, Rani KGA, AlKawas S, et al. Eva-luation of the osteogenic potential of demineralized and decellularized bovine bone granules following implan-tation in rat calvaria critical-size defect model. PLoS One. 2023;18(12):e0294291. doi: https://doi.org/10.1371/journal.pone.0294291
Basal O, Ozmen O, Deliormanli AM. Effect of polycaprolactone scaffolds containing different weights of graphene on healing in large osteochondral defect model. J Biomater Sci Polym Ed. 2022;33(9):1123-39. doi: https://doi.org/10.1080/09205063.2022.2042035
Dang L, Zhu J, Song C. The effect of topical administration of simvastatin on entochondrostosis and intra¬membranous ossification: An animal experiment. J Orthop Translat. 2021;28:1-9. doi: https://doi.org/10.1016/j.jot.2020.11.009
Cen C, Zhang Y, Cao Y, et al. Construction of a 3D Degradable PLLA/β-TCP/CS Scaffold for Establishing an Induced Membrane Inspired by the Modified Single-Stage Masquelet Technique. ACS Biomater Sci Eng. 2025;11(3):1629-45. doi: https://doi.org/10.1021/acsbiomaterials.4c01849
Yiğit U, Kırzıoğlu FY, Özmen Ö. Effects of low dose doxycycline and caffeic acid phenethyl ester on sclerostin and bone morphogenic protein-2 expressions in experimental periodontitis. Biotech Histochem. 2022;97(8):567-75. doi: https://doi.org/10.1080/10520295.2022.2036370
Gao J, Zhang G, Xu K, et al. Bone marrow mesenchymal stem cells improve bone erosion in collagen-induced arthritis by inhibiting osteoclasia-related factors and differentiating into chondrocytes. Stem Cell Res Ther. 2020;11(1):171.
doi: https://doi.org/10.1186/s13287-020-01684-w
Fawaz A, Mohammed MM, Ismail A, Rani KGA, Samsudin AR. The influence of simvastatin on osteoblast functionality in the presence of titanium dioxide particles In-vitro. Arch Oral Biol. 2024;167:106065. doi: https://doi.org/10.1016/j.archoralbio.2024.106065
Fiorin LG, Matheus HR, Ervolino E, et al. Tamoxifen improves homeostasis in the peri-implant bone remodeling of osseointegrated titanium implants. J Perio-dontal Res. 2022;57(4):880-90. doi: https://doi.org/10.1111/jre.13026
Ke Re Mu ALM, Abulikemu M, Liang Z, Abulikemu A, Tuxun A. Anti-Infection Efficacy, Osteogenesis Potential, and Biocompatibility of 3D Printed PLGA/Na-no-Hydroxyapatite Porous Scaffolds Grafted with Van-comycin/DOPA/rhBMP-2 in Infected Rabbit Bone De-fects. Int J Nanomedicine. 2025;20:6399-421. doi: https://doi.org/10.2147/IJN.S514978
Kim JE, Takanche JS, Jang S, Yi HK. Mussel adhesive protein blended with gelatin loaded into nanotube titanium dental implants enhances osseointegration. Drug Deliv Transl Res. 2021;11(3):956-65. doi: https://doi.org/10.1007/s13346-020-00807-3
Durand M, Oger M, Nikovics K, et al. Influence of the Immune Microenvironment Provided by Implanted Biomaterials on the Biological Properties of Masquelet-Induced Membranes in Rats: Metakaolin as an Alternative Spacer. Biomedicines. 2022;10(12):3017. doi: https://doi.org/10.3390/biomedicines10123017
Loskutov O, Shponka I, Bondarenko O, Bondarenko N, Bozhko A. Histological and histochemical asses-sment of short-term events in peri-implant bone for osteoinductivity evaluation of functional-protective implant coatings. Medicni perspektivi 2021;26(3):4-10. doi: https://doi.org/10.26641/2307-0404.2021.3.241875
Bondarenko OO, Bozhko AH, Skoryk MA, Bondarenko NS, Shponka IS, Loskutov OY. Peri-implant osteogenesis on alumina-coated titanium implants in rat femur: morphological and elemental analysis of implant surfaces. Pathologia. 2024;21(2):132-40. doi: https://doi.org/10.14739/2310-1237.2024.2.306822
Sanderson T, Wild G, Cull AM, Marston J, Zardin G. Immunohistochemical and immunofluorescent techniques. In: Suvarna SK, Layton C, Bancroft JD, edi-tors. Bancroft’s Theory and Practice of Histological Techniques. 8th ed. Elsevier; 2019. p. 337-94. doi: https://doi.org/10.1016/B978-0-7020-6864-5.00019-0
Hak T, Dul J. Pattern matching. In: Mills AJ, Durepos G, Wiebe E, editors. Encyclopedia of case study research. Thousand Oaks (CA): SAGE; 2010. p. 664-6.
Claes L, Recknagel S, Ignatius A. Fracture healing under healthy and inflammatory conditions. Nat Rev Rheumatol. 2012 Jan 31;8(3):133-43. doi: https://doi.org/10.1038/nrrheum.2012.1
Camilo CC, Silveira CAE, Faeda RS, de Almeida Rollo JMD, Purquerio BM, Fortulan CA. Bone response to porous alumina implants coated with bioactive materials, observed using different characterization techniques. J Appl Biomater Funct Mater. 2017;15(3):e223-e235. doi: https://doi.org/10.5301/jabfm.5000347
Lukaszewska-Kuska M, Wirstlein P, Majchrowski R, Dorocka-Bobkowska B. The effects of titanium to-pography and chemical composition on human osteoblast cell. Physiol Res. 2021;70(3):413-23. doi: https://doi.org/10.33549/physiolres.934582
Zeiter S, Koschitzki K, Alini M, Jakob F, Rudert M, Herrmann M. Evaluation of Preclinical Models for the Testing of Bone Tissue-Engineered Constructs. Tissue Eng Part C Methods. 2020;26(2):107-17. doi: https://doi.org/10.1089/ten.TEC.2019.0213
Blanc-Sylvestre N, Bouchard P, Chaussain C, Bardet C. Pre-Clinical Models in Implant Dentistry: Past, Present, Future. Biomedicines. 2021;9(11):1538. doi: https://doi.org/10.3390/biomedicines9111538
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Medicni perspektivi

This work is licensed under a Creative Commons Attribution 4.0 International License.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.



